24 Jun 2024
10:45
Federal Institutions
The FAMHP publishes its 2023 annual report: all our figures, results and main projects
Although 2023 saw an increase in notifications regarding temporary unavailability of medicines, the agency once again demonstrated its effectiveness in ensuring the most efficient possible management of medicine stocks, as in the case of thrombolytics. The FAMHP also played its part in protecting public health by increasing the number of investigations into illegal medicines and devices by 30 %, and of inspections of pharmacies open to the public by over 40 %.
Federal Agency for Medicines and Health Products (FAMHP)